These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36297417)

  • 1. 2D NMR Analysis as a Sensitive Tool for Evaluating the Higher-Order Structural Integrity of Monoclonal Antibody against COVID-19.
    Cantini F; Andreano E; Paciello I; Ghini V; Berti F; Rappuoli R; Banci L
    Pharmaceutics; 2022 Sep; 14(10):. PubMed ID: 36297417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the 2D
    Hwang TL; Batabyal D; Knutson N; Wikström M
    Molecules; 2021 May; 26(9):. PubMed ID: 34063095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NMR spectroscopy as a characterization tool enabling biologics formulation development.
    Ma J; Pathirana C; Liu DQ; Miller SA
    J Pharm Biomed Anal; 2023 Jan; 223():115110. PubMed ID: 36308923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enabling adoption of 2D-NMR for the higher order structure assessment of monoclonal antibody therapeutics.
    Brinson RG; Marino JP; Delaglio F; Arbogast LW; Evans RM; Kearsley A; Gingras G; Ghasriani H; Aubin Y; Pierens GK; Jia X; Mobli M; Grant HG; Keizer DW; Schweimer K; Ståhle J; Widmalm G; Zartler ER; Lawrence CW; Reardon PN; Cort JR; Xu P; Ni F; Yanaka S; Kato K; Parnham SR; Tsao D; Blomgren A; Rundlöf T; Trieloff N; Schmieder P; Ross A; Skidmore K; Chen K; Keire D; Freedberg DI; Suter-Stahel T; Wider G; Ilc G; Plavec J; Bradley SA; Baldisseri DM; Sforça ML; Zeri ACM; Wei JY; Szabo CM; Amezcua CA; Jordan JB; Wikström M
    MAbs; 2019 Jan; 11(1):94-105. PubMed ID: 30570405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMR based quality evaluation of mAb therapeutics: A proof of concept higher order structure biosimilarity assessment of trastuzumab biosimilars.
    Joshi S; Khatri LR; Kumar A; Rathore AS
    J Pharm Biomed Anal; 2022 May; 214():114710. PubMed ID: 35290923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemometric Outlier Classification of 2D-NMR Spectra to Enable Higher Order Structure Characterization of Protein Therapeutics.
    Sheen DA; Shen VK; Brinson RG; Arbogast LW; Marino JP; Delaglio F
    Chemometr Intell Lab Syst; 2020; 199():. PubMed ID: 34135539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher-Order Structure Characterization of Pharmaceutical Proteins by 2D Nuclear Magnetic Resonance Methyl Fingerprinting.
    Haxholm GW; Petersen BO; Malmstrøm J
    J Pharm Sci; 2019 Sep; 108(9):3029-3035. PubMed ID: 31082403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the Higher-Order Structure of Formulated Monoclonal Antibody Therapeutics by 2D Methyl Correlated NMR and Principal Component Analysis.
    Arbogast LW; Delaglio F; Brinson RG; Marino JP
    Curr Protoc Protein Sci; 2020 Jun; 100(1):e105. PubMed ID: 32407007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multivariate Analysis of Two-Dimensional
    Arbogast LW; Delaglio F; Schiel JE; Marino JP
    Anal Chem; 2017 Nov; 89(21):11839-11845. PubMed ID: 28937210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Comparison Between Emerging and Current Biophysical Methods for the Assessment of Higher-Order Structure of Biopharmaceuticals.
    Wen J; Batabyal D; Knutson N; Lord H; Wikström M
    J Pharm Sci; 2020 Jan; 109(1):247-253. PubMed ID: 31669605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2D (1)H(N), (15)N Correlated NMR Methods at Natural Abundance for Obtaining Structural Maps and Statistical Comparability of Monoclonal Antibodies.
    Arbogast LW; Brinson RG; Formolo T; Hoopes JT; Marino JP
    Pharm Res; 2016 Feb; 33(2):462-75. PubMed ID: 26453189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Principal component analysis for automated classification of 2D spectra and interferograms of protein therapeutics: influence of noise, reconstruction details, and data preparation.
    Brinson RG; Elliott KW; Arbogast LW; Sheen DA; Giddens JP; Marino JP; Delaglio F
    J Biomol NMR; 2020 Nov; 74(10-11):643-656. PubMed ID: 32700053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of High Resolution NMR Methods to Probe the Impact of Chemical Modifications on Higher Order Structure of Monoclonal Antibodies in Relation to Antigen Binding.
    Majumder S; Saati A; Philip S; Liu LL; Stephens E; Rouse JC; Alphonse Ignatius A
    Pharm Res; 2019 Jul; 36(9):130. PubMed ID: 31264003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the Analytical Superiority of 1D NMR for Fingerprinting the Higher Order Structure of Protein Therapeutics Compared to Multidimensional NMR Methods.
    Poppe L; Jordan JB; Rogers G; Schnier PD
    Anal Chem; 2015 Jun; 87(11):5539-45. PubMed ID: 25929316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Best Practices in Utilization of 2D-NMR Spectral Data as the Input for Chemometric Analysis in Biopharmaceutical Applications.
    Brinson RG; Arbogast LW; Marino JP; Delaglio F
    J Chem Inf Model; 2020 Apr; 60(4):2339-2355. PubMed ID: 32249579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid-State NMR Characterization of Lyophilized Formulations of Monoclonal Antibody Therapeutics.
    Perodeau J; Arbogast LW; Nieuwkoop AJ
    Mol Pharm; 2023 Mar; 20(3):1480-1489. PubMed ID: 36702622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2D J-correlated proton NMR experiments for structural fingerprinting of biotherapeutics.
    Brinson RG; Marino JP
    J Magn Reson; 2019 Oct; 307():106581. PubMed ID: 31499472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlated analytical and functional evaluation of higher order structure perturbations from oxidation of NISTmAb.
    Solomon TL; Delaglio F; Giddens JP; Marino JP; Yu YB; Taraban MB; Brinson RG
    MAbs; 2023; 15(1):2160227. PubMed ID: 36683157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of Natural Isotopic Abundance ¹H-¹³C- and ¹H-¹⁵N-Correlated Two-Dimensional NMR for Evaluation of the Structure of Protein Therapeutics.
    Arbogast LW; Brinson RG; Marino JP
    Methods Enzymol; 2016; 566():3-34. PubMed ID: 26791974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMR Spectroscopy for Protein Higher Order Structure Similarity Assessment in Formulated Drug Products.
    Wang D; Zhuo Y; Karfunkle M; Patil SM; Smith CJ; Keire DA; Chen K
    Molecules; 2021 Jul; 26(14):. PubMed ID: 34299526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.